Episodes

  • The Back Door: How a Company Became Public Without an IPO
    Sep 21 2026

    Everyone asks what a company does, what it earns, who runs it. Almost nobody asks how it became public in the first place, and in this corner of the market that answer explains more than the business plan does. Atlas and Michael cover the reverse merger: a private business buys a public shell left behind by a company that failed, and wakes up listed the next morning. No prospectus, no underwriter, no roadshow, and none of the four things a traditional offering quietly produces. They cover what the shell brings with it, the block of holders sitting on stock bought at a fraction of a cent, the filing that functions as a prospectus after the fact, and why the exchanges now make these companies wait a year before uplisting. They also disagree about whether choosing the back door tells you something about management, which is the argument at the center of the episode.


    Show More Show Less
    14 mins
  • The First Rate Hike Since 2023 (Weekly Roundup)
    Sep 21 2026

    The Fed raised rates a quarter point to 3.75%–4.00% on Wednesday, the first increase since 2023, unanimously, with 16 of 18 officials now projecting at least one more before year end. But the decision was expected and the thing underneath it was not. The 10-year Treasury finished the week above 5%, and the 2-year reached its highest level since mid-2024. Atlas and Michael explain why that number matters more than the Fed's, why an investor earning 5% risk-free changes the math on every unprofitable company in the market, and why the terms on the next small-cap financing just got worse regardless of what those businesses did. Plus the split underneath a calm-looking week: the Dow had its worst week since March while technology shrugged off higher rates entirely, which is either conviction or a position waiting to be tested. Commentary and education only, never advice.


    Show More Show Less
    9 mins
  • Roundup (week of September 7–11)
    Sep 14 2026

    Four sessions after the holiday, and the week split cleanly in half. Oil ran it: escalating conflict involving the United States and Iran pushed Brent toward $110 a barrel before it eased to around $104, still up more than 8% on the week. Stocks fell four days straight and Treasury yields set new one-year highs. Then Friday's August inflation report came in slightly hot, core prices up 0.3% against 0.2% expected, and odds of a Fed hike jumped to roughly 85% from a coin flip a week earlier. The market rallied about 1% across the board anyway. Atlas explains why a bad certainty beats a good maybe, why an oil shock is an inflation problem rather than an energy one, and why small caps have now outperformed twice on days the rate news went against them. Commentary and education only, never advice.


    Show More Show Less
    6 mins
  • You Can Buy It. Can You Sell It?
    Sep 14 2026

    Every episode so far has asked whether a company is any good. This one skips that and asks something simpler that almost nobody puts first. You bought it, can you sell it? In a micro-cap the honest answer is often not at that price, and not today. Atlas and Michael cover the spread that puts you down eight percent the moment you buy, why the quoted price only applies to a few hundred shares, and what happens to your average sale price when you try to move ten thousand. Then the one number to check before buying, why position size in this corner of the market is decided by exit rather than conviction, and why liquidity is thinnest exactly when you need it most.


    Show More Show Less
    7 mins
  • Double Roundup: The Jobs Report That Got Revised Away
    Sep 7 2026

    Two weeks in one episode, and there is a reason for it. These weeks turned out to be a single story, and reading either one alone gives you the wrong conclusion. Week one: Nvidia guided to roughly 70% revenue growth against Wall Street's 45%, rose 8.7% the next day, and dragged the chip complex with it, while the Fed chair used his first Jackson Hole keynote to say there is more work to do on inflation. Week two: August payrolls came in at 162,000 against expectations near 55,000, and July was revised from a loss of 23,000 jobs to a gain of 21,000. That negative print, the one that anchored the entire August rate-cut rally, never actually happened. Atlas and Michael walk through what a revision that size does to a market pricing central bank decisions off every release, and what a rising cost of capital means for companies that have to raise money to keep going. Commentary and education only, never advice.


    Show More Show Less
    10 mins
  • The Delisting Clock: The One Deadline That Is Actually Dated
    Sep 7 2026

    Almost nothing in a small company filing comes with a date attached. Going concern language tells you a company may not survive, but not when. A shelf tells you shares may be sold, but not which day. There is one exception, and it is the exchange listing rules. Atlas and Michael cover the clock: the thirty consecutive days below a dollar that trigger it, the letter the company must disclose within four business days, the one hundred eighty days to cure and what curing actually requires, the second window and the reverse split it usually implies, and the hearing that can stretch the whole thing to roughly a year. Then the part that matters most in this segment. Losing an exchange listing can cost a company its fast path to raising money, at exactly the moment it needs to raise fastest.


    Show More Show Less
    11 mins
  • The Auditor Walked: Reading a Change of Accountant
    Aug 31 2026

    A small company files a document on a Tuesday afternoon. It is under a page, there is no press release attached, and no headline anywhere. It says the company has a new accounting firm. That filing can be the loudest thing a company publishes all year. Atlas and Michael read it properly: why resigned and dismissed mean completely different things, why the reassuring line about no disagreements is nearly meaningless, and the one exhibit almost nobody opens, where the departing accountant goes on the record about whether the company's version is true.


    Show More Show Less
    13 mins
  • The Spike: What a Company Does the Morning After Good News
    Aug 24 2026

    A drug company posted results on an experimental cancer treatment and gained 177% in a single session. The next day it handed back a quarter of that. No new information in between. Atlas and Michael use that pattern to explain the binary catalyst: one event, one date, and a price that reprices in seconds rather than days. Then the part almost nobody watches for. After a spike, supply arrives from three directions, and the third is the company itself. A stock that triples is a financing window, and windows close, which is why the raise often lands within days rather than months. What to check while the excitement is still running: whether an effective shelf is already on file, how much cash the business holds against what it burns, and why reading the actual disclosure instead of the press release explains most of the next-day giveback. Commentary and education only, never advice.


    Show More Show Less
    8 mins